Federated Hermes Short Duration Corporate ETF (NYSEARCA:FCSH – Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totaling 11,083 shares, a decline of 47.0% from the September 30th total of 20,898 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 1,262 shares, the short-interest ratio is presently 8.8 days.
Institutional Trading of Federated Hermes Short Duration Corporate ETF
An institutional investor recently raised its position in Federated Hermes Short Duration Corporate ETF stock. Cordgrass Capital Advisors LLC lifted its position in Federated Hermes Short Duration Corporate ETF (NYSEARCA:FCSH – Free Report) by 80.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,222 shares of the company’s stock after acquiring an additional 992 shares during the period. Cordgrass Capital Advisors LLC owned 0.08% of Federated Hermes Short Duration Corporate ETF worth $52,000 as of its most recent SEC filing.
Federated Hermes Short Duration Corporate ETF Price Performance
Shares of NYSEARCA FCSH traded up $0.01 during midday trading on Monday, hitting $23.82. 5,802 shares of the company traded hands, compared to its average volume of 1,744. Federated Hermes Short Duration Corporate ETF has a 12-month low of $23.57 and a 12-month high of $24.64. The stock has a 50-day moving average price of $23.81 and a 200 day moving average price of $24.16.
About Federated Hermes Short Duration Corporate ETF
The Federated Hermes Short Duration Corporate ETF (FCSH) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund seeks high current income through the active management of short-term US dollar-denominated corporate debt securities that are rated investment-grade. FCSH was launched on Dec 16, 2021 and is managed by Federated Hermes.
Further Reading
- Five stocks we like better than Federated Hermes Short Duration Corporate ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Federated Hermes Short Duration Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Federated Hermes Short Duration Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
